Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease (original) (raw)
Related papers
Journal of the Neurological Sciences, 2000
Dopamine agonists in the treatment of non-motor symptoms of Parkinson’s disease: depression
European Journal of Neurology, 2008
Drug treatment strategies for depression in Parkinson disease
Expert Opinion on Pharmacotherapy, 2019
Parkinson's disease severity and use of dopaminergic medications
Parkinsonism & Related Disorders, 2015
Depression in Parkinson's disease - a review
Acta Neurologica Scandinavica, 2006
Depression in Parkinson Disease: Current Understanding and Treatment
International Journal of Gerontology, 2008
Drugs & Aging, 2015
Medicina
Depressive symptoms in Parkinson's disease
2012
Depression in Parkinson’s disease: Health risks, etiology, and treatment options
Neuropsychiatric Disease and Treatment, 2008
Prevalence and Treatment of Depression in Parkinson's Disease
Journal of Neuropsychiatry, 2005
Depression in Parkinson's disease: health risks, etiology, and treatment options
Neuropsychiatric Disease and Treatment, 2008
Depression and Parkinson’s Disease: Current Knowledge
Current Neurology and Neuroscience Reports, 2013
Depression in Parkinson's disease: study of 60 cases
Arquivos de Neuro-Psiquiatria, 2002
Neuroscience & Biobehavioral Reviews, 2011
Factors associated with depression in Parkinson's disease
Rodney Marsh, John O'Sullivan, Peter Silburn
Journal of Affective Disorders, 2011
Depression in Parkinson’s Disease: The Contribution from Animal Studies
Parkinson's Disease, 2017
Anxious and depressive symptoms in Parkinson's disease: The French cross-sectionnal DoPaMiP study
Movement Disorders, 2010
European Journal of Neurology, 2005
Journal of Neurology, Neurosurgery & Psychiatry, 2020
Antidepressant studies in Parkinson's disease: A review and meta-analysis
Movement Disorders, 2005
Dopaminergic modulation of memory and affective processing in Parkinson depression
Psychiatry Research, 2013
European Journal of Neurology, 2013
Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010